Tags - leukemia

FDA approves treatment for 'hairy cell' leukemia

TEHRAN, September 15 -Lumoxiti injection has been approved to treat certain instances of relapsed or refractory "hairy cell" leukemia , or HCL, the U.S. Food and Drug Administration said Thursday.

News ID: 28853 Publish Date : 2018/09/15

Young journalists club

FDA approves treatment for 'hairy cell' leukemia

China’s EXIM inks $1.5bn deal for high-speed rail in Iran (1 Comment)